-
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
-
Twist Bioscience Corporation (TWST) and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
-
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
-
Twist Bioscience Corporation (TWST) Enters Deal with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
-
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
-
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
-
Twist Bioscience Corporation (TWST) and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
-
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
-
Twist Bioscience Corporation (TWST) Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
-
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
-
Twist Bioscience Corporation (TWST) Appoints Chet Gandhi as Chief Information Officer
-
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
-
Twist Bioscience Corporation (TWST) and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
-
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
-
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
-
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
-
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results

